ALX Oncology Holdings Inc. (ALXO) Misses Q3 EPS by 4c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q3 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• XP Inc. (XP) Tops Q2 EPS by 8c
• BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform